Literature DB >> 4577392

Double-blind study of cyclophosphamide in rheumatoid arthritis.

M D Lidsky, J T Sharp, S Billings.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4577392     DOI: 10.1002/art.1780160203

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  7 in total

1.  Methotrexate therapy in rheumatoid arthritis. A two year prospective follow-up.

Authors:  A A Drosos; D Psychos; A P Andonopoulos; S Stefanaki-Nikou; E B Tsianos; H M Moutsopoulos
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

Review 2.  A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question?

Authors:  T Pullar; H A Capell
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

Review 3.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

Review 4.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 5.  Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis.

Authors:  M Arnold; L Schrieber; P Brooks
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

Review 6.  Remission-inducing drugs in rheumatoid arthritis.

Authors:  T P Anastassiades
Journal:  Can Med Assoc J       Date:  1980-02-23       Impact factor: 8.262

7.  Calcaneus bone mineral density in Japanese women with rheumatoid arthritis.

Authors:  S Doi; K Kushida; S Miyamoto; Y Sekioka; M Suzuki; T Inoue; A Nagano
Journal:  Rheumatol Int       Date:  2004-02-27       Impact factor: 2.631

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.